CroíValve is an early stage medical device company focused on developing a minimally invasive device for the treatment of tricuspid regurgitation. It is based in Dublin, Ireland and combines significant clinical, technical and commercial experience.

Dr Lucy O’Keeffe: CEO

Lucy has held cross-functional leadership positions managing complex global medical/ clinical device programs in Medtronic, Nypro Healthcare and ICON PLC. She holds a degree in Mechanical Engineering from University College Dublin and PhD in Biomedical Engineering from University of Limerick

Dr Martin Quinn: CMO

Martin is a consultant Interventional Cardiologist in St Vincent’s University Hospital and Blackrock Clinic with in-depth knowledge of the disease state and percutaneous methodologies to treat cardiovascular disease. He completed an interventional cardiology fellowship in the Cleveland Clinic

Dr Ivan Vesely: CTO

Ivan is an expert in heart valve design and tissue biomechanics. He previously founded Valvexchange, an aortic heart valve company. He was an Endowed Professor of Bioengineering and Cardiothoracic Surgery at the University of Southern California and he established the Heart Valve Laboratory at Cleveland Clinic.    He holds a degree in Electrical Engineering and PhD in Biophysics